By Al Wild // Updated: April 12, 2017 .Zacks Investment Research has Downgraded PHARMA MAR EUR0.05 (NASDAQ:PHMMF) to Sell in a Statement released on 4/12/2017.
Boasting a price of $3.51, PHARMA MAR EUR0.05 (NASDAQ:PHMMF) traded 9.01% higher on the day. With the last stock price close up 19.03% from the two hundred day average, compared with the S&P 500 Index which has increased 0.03% over the date range.
PHARMA MAR EUR0.05 has recorded a 50-day average of $3.07 and a two hundred day average of $2.95. Volume of trade was down over the average, with 10,700 shares of PHMMF changing hands under the typical 12,955 .
...